As a passionate feminist, when presented with an opportunity to build on pivotal research conducted in collaboration between two of Denmark’s most prestigious universities, and use this to form the basis of a groundbreaking women’s health company, she could not resist. Ella has since set out to forge a novel and innovative treatment for vaginal infections and accelerate advances in women’s healthcare.

Since starting UVISA, Ella, along with the rest of the team, have won several competitions and awards of recognition within both the Danish entrepreneurship ecosystem and further afield. These include the Venture Cup Health Category 2021, Plougmann Vingtoft “IP Matters” Competition 2021, PDMA Global Student Innovation Challenge 2021, DTU X-Tech Final December 2021, the BII Sten Scheibye Award 2022, and were a finalist in the Danish Tech Challenge 2022. She has also established research partnerships with key opinion leaders at Statens Serum Institut, Region Hovedstaden, and København Universitet. While founding UVISA, she completed an MSc. in Technology Entrepreneurship at Danmarks Tekniske Universitet (DTU).

Through her research, Sonal has explored the impact of combining probiotics with standard & extended antimicrobial treatments for vaginal dysbiosis in highly recurrent cases, examining cure rates, prevention/delayed relapse, and engineering microbes to produce antiviral nanobodies. Her expertise extends beyond research as well, and as the Chief Product Officer and Medical Science Lead at Briota Technologies, a digital health and wellness company specializing in pulmonary disease management, she led the development of a digital product tailored to the needs of Danish and European markets. Here, she spearheaded the design of an early feasibility clinical study, and established relationships with KOL/Principal Investigator for conducting clinical trials in Denmark.

Currently, Sonal is channeling her extensive knowledge of the vaginal microbiome and her experience in healthcare technology and clinical trials into her work and driving the development of non-pharmacological treatments for vaginal infections at UVISA. Through her efforts, Sonal aims to bring accessible, science-driven solutions to women worldwide, furthering her mission to revolutionize women’s health.

Over the past years, Andra has built a multidisciplinary design practice rooted in clarity, consistency, and collaboration across the full spectrum of brand and marketing design. Working across several Danish start-ups and scale-ups, she has led company-wide rebrands, crafted brand identities from the ground up, and helped sharpen positioning through strategic storytelling and high-performing design. Andra has also played a key role in aligning brands with product and commercial strategy—creating campaigns, launch assets, and digital experiences that improve visibility, engagement, and conversion. At UVISA, she helps build a brand that speaks with credibility, purpose, and impact in the women’s health space. Outside of work, Andra loves videography and music, and she wastes no opportunity to go outside and be in nature whenever the sun is out.

Dominic has led teams and projects at companies such as Chiaro Technology (Elvie), where he transformed early-stage prototypes into fully certified, mass-produced medical devices. His experience spans the full product lifecycle, from proof-of-concept, through to design transfer, regulatory compliance, and ongoing production support. He thrives in multidisciplinary environments and is driven by a desire to build high-quality electronics that make a meaningful difference. Outside of work, Dominic is a hands-on DIY enthusiast with a deep passion for sustainable tech; particularly solar, EVs, and heat pumps. He enjoys building and optimising home energy systems and exploring green innovation - all while being a proud dad to two awesome children who keep life fun, busy, and full of inspiration.

Joining UVISA on a fixed-term basis, he remains full-time to develop and maintain our Quality Management System (QMS) in preparation for our upcoming ISO 13485 certification and obtaining Market Approvals. Laurynas has built a versatile career spanning healthcare service provision, product development, regulatory compliance, market analysis, and stakeholder management. He has worked on projects ranging from CE Class I-IIb medical devices tackling chronic and acute disease cases to pharmaceutical therapy and health care service optimization. Outside of work, he enjoys competitive sports such as racing, and also finds applied sciences interesting, altogether reflecting his drive for continuous improvement. Laurynas will bring this same mindset to help UVISA achieve the highest quality standards.